Hormone Therapy After Age 65: What the New Research Really Says
A new large-scale study published in Menopause, the journal of The Menopause Society, is helping clarify an important question many women ask: Is hormone therapy safe and effective after age 65?
Hormone therapy (HT) remains one of the most effective treatments for hot flashes and other menopausal symptoms. Current guidelines have traditionally recommended starting therapy before age 60 or within 10 years of menopause onset. However, real-world experience shows that many women continue to have significant symptoms well beyond age 65 — and some begin therapy later.
This new study followed more than 83,000 women over a 22-year period and examined health outcomes in those who started or continued hormone therapy after age 65.
Key Findings From the Study
The research showed that:
• Hormone therapy continues to be effective for symptom relief in older women
• Starting hormone therapy at age 65 or later was associated with higher risks of certain conditions
• Risks included increased rates of cancer (especially breast cancer), stroke, and heart disease
• Longer duration of hormone therapy use was linked with higher overall health risk
• Early apparent heart benefits seen in younger starters were not confirmed after statistical adjustment
Does This Mean Women Over 65 Should Never Use Hormones?
No — and this is an important point.
The Menopause Society emphasizes that there is no universal age cutoff that automatically requires women to stop hormone therapy. Instead, the recommendation is individualized care.
For healthy women with persistent, quality-of-life-limiting symptoms, continuing therapy beyond age 65 may be reasonable — if it is done with:
• Careful risk-benefit evaluation
• Appropriate dosing and regimen selection
• Ongoing medical monitoring
• Regular reassessment
• Consideration of non-hormonal alternatives when appropriate
Important Study Limitations
The researchers also noted that the study did not include details on hormone formulation, dose, route of delivery (such as transdermal vs oral), or progestogen use — all factors known to influence risk. Because this was an observational study, it cannot prove cause-and-effect relationships.
What This Means for Patients
This study reinforces what menopause specialists have been moving toward for years: personalized hormone therapy decisions.
The right question is not simply:
“Is hormone therapy safe after 65?”
The better question is:
“Is hormone therapy appropriate for this woman, at this time, with this health profile?”
At Vitality Collective Hormone Health, we follow an individualized, evidence-informed approach — evaluating symptoms, labs, risk factors, delivery methods, and ongoing response — rather than using one-size-fits-all rules.
If you’re over 65 and still struggling with menopausal symptoms, there may be options — but they should be explored thoughtfully and with expert guidance.
Source: The Menopause Society
Another long-term study adds important context to this conversation.
The Leisure World Cohort Study followed 8,801 postmenopausal women, with an average starting age in the early 70s, for over 20 years. Researchers examined prior estrogen use and long-term mortality outcomes. Women who had ever used estrogen therapy had lower all-cause mortality compared to women who had never used it. The association was stronger in women who used estrogen for longer durations, particularly those who used it for 15 years or more. More recent use at the time of enrollment was also associated with lower mortality compared to more remote use.
Importantly, this was an observational study, not a randomized controlled trial, so it does not prove causation. Most of the women who used estrogen began therapy closer to menopause rather than initiating it for the first time in their late 60s or 70s. That distinction matters. Timing, duration, baseline cardiovascular health, and overall metabolic status all influence risk and benefit.
What this study reinforces is that hormone therapy is not a simple yes-or-no decision based solely on age. There are signals suggesting that long-term, appropriately selected estrogen use may be associated with longevity in some women. At the same time, initiation later in life requires careful evaluation, especially in the presence of established atherosclerosis or cardiovascular disease.
The takeaway is not that every woman over 65 should begin hormone therapy. The takeaway is that individualized risk assessment, thoughtful timing, route of administration, and collaboration with cardiology and primary care matter. Age alone should not automatically close the door.
Not medical advice
This blog is for education only and is not medical advice. Supplements can interact with medications and medical conditions. Always talk with your licensed clinician before starting or changing a supplement routine—especially if you are pregnant, breastfeeding, managing a chronic condition, or taking prescription medications.
If you want more information or support, book a free 20 minute wellness consultation with us - call 844-662-3288 or book online.
